|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.91 USD | +3.87% |
|
+5.64% | +170.77% |
| 05-06 | Tango Therapeutics Insider Sold Shares Worth $573,097, According to a Recent SEC Filing | MT |
| 04-15 | Tango Therapeutics Names Matthew Gall as CFO | MT |
| Capitalization | 3.32B 2.82B 2.58B 2.44B 4.55B 314B 4.59B 30.63B 11.94B 151B 12.46B 12.2B 520B | P/E ratio 2026 * |
-17.2x | P/E ratio 2027 * | -14.5x |
|---|---|---|---|---|---|
| Enterprise value | 3.32B 2.82B 2.58B 2.44B 4.55B 314B 4.59B 30.63B 11.94B 151B 12.46B 12.2B 520B | EV / Sales 2026 * |
548x | EV / Sales 2027 * | 1,057x |
| Free-Float |
98.26% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tango Therapeutics, Inc.
| 1 day | +3.87% | ||
| 1 week | +5.64% | ||
| Current month | +10.96% | ||
| 1 month | +11.27% | ||
| 3 months | +90.25% | ||
| 6 months | +186.28% | ||
| Current year | +170.77% |
| 1 week | 22.36 |  | 24.58 |
| 1 month | 20.09 | | 28.41 |
| Current year | 8.66 | | 28.41 |
| 1 year | 1.07 | | 28.41 |
| 3 years | 1.03 | | 28.41 |
| 5 years | 1.03 | | 28.41 |
| 10 years | 1.03 | | 28.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Malte Peters
CEO | Chief Executive Officer | 63 | 2026-01-07 |
Matthew Gall
DFI | Director of Finance/CFO | 49 | 2026-04-14 |
| Chief Tech/Sci/R&D Officer | - | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Weber
CHM | Chairman | 69 | 2026-01-07 |
Alexis Borisy
CHM | Chairman | 54 | - |
Malte Peters
BRD | Director/Board Member | 63 | 2018-08-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.87% | +5.64% | +1,731.30% | +548.38% | 3.32B | |
| -0.25% | +0.54% | -16.33% | -16.47% | 43.39B | |
| +1.34% | +6.71% | +35.94% | +29.64% | 34.7B | |
| +1.40% | -2.93% | +242.79% | +460.34% | 30.15B | |
| -2.10% | +8.31% | +11.65% | -8.19% | 29.83B | |
| -3.58% | -4.59% | +25.92% | +23.61% | 28.46B | |
| -0.17% | +5.22% | - | - | 14.82B | |
| -3.84% | +3.05% | +127.95% | +4,325.52% | 14.48B | |
| +0.81% | +1.45% | +128.29% | +115.07% | 12.51B | |
| -1.38% | +1.14% | +4.24% | -3.43% | 12.29B | |
| Average | -0.42% | +3.81% | +254.64% | +608.27% | 22.39B | |
| Weighted average by Cap. | -0.65% | +3.46% | +87.04% | +384.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.06M 5.15M 4.71M 4.45M 8.29M 572M 8.37M 55.88M 21.78M 275M 22.73M 22.25M 949M | 3.14M 2.67M 2.44M 2.3M 4.3M 297M 4.34M 28.97M 11.29M 142M 11.78M 11.53M 492M |
| Net income | -186M -158M -144M -136M -254M -17.54B -256M -1.71B -668M -8.42B -697M -682M -29.08B | -239M -203M -186M -176M -328M -22.62B -331M -2.21B -861M -10.86B -898M -880M -37.51B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-11 | 23.99 $ | +4.21% | 350,499 |
| 26-05-08 | 23.02 $ | -1.96% | 1,511,453 |
| 26-05-07 | 23.48 $ | -0.59% | 6,973,080 |
| 26-05-06 | 23.62 $ | -2.40% | 1,475,770 |
| 26-05-05 | 24.20 $ | +6.56% | 2,224,330 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TNGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition